Resources

Start on Insulin not sulfonylurea for better control and save beta cells. Study Suggests It Helps Patients Maintain Metabolic Control. For patients recently diagnosed with adult-onset (i.e., type 2) diabetes, insulin treatment achieves better results than does therapy with oral medication, Swedish researchers report.

Losartan may better protect diabetics against cardiac death from arrhythmias than atenolol.

Over 300 million now have Pre-Diabetes and expected to grow to 472 million says, the President of the International Diabetes Federation (IDF), who is calling for changes in eating habits and lifestyle.

Administration of usual therapeutic doses of gemfibrozil considerably increases the plasma concentrations of rosiglitazone 10-fold, an insulin-sensitizing drug used to treat patients with Type 2 diabetes mellitus.

Treating dyslipidemia in patients with type 2 diabetes mellitus without cardiovascular disease appears to result in a clinical benefit equivalent to or greater than that seen with treating non-diabetic cardiovascular disease patients.

Using a standard blood pressure (BP) cuff in obese subjects may result in overestimation of BP.

Treatment with rosiglitazone reduces hyperinsulinemia and improves artery elasticity in type 2 diabetic patients.

Insulin treatment achieves better results in patients with recent onset type 2 diabetes than does therapy with glibenclamide.

Pentoxifylline (PTF) reduces proteinuria and urinary excretion of N-acetyl-beta glucosaminidase (NAG) in patients with type 2 diabetes.

New defintion for metabolic syndrome consists of five easily measured variables linked to insulin reststance.